SCHEMBL1007967

SCHEMBL1007967

NC(=O)CN1CCC[C@@H](F)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
BCHE P06276 1/20 0.36
DPP4 P27487 6/20 0.36
DPP7 Q9UHL4 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CHRM5 P08912 2/20 0.35
CHRM1 P11229 2/20 0.35
SIGMAR1 Q99720 2/20 0.35
GAA P10253 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM3 P20309 1/20 0.35
GRM2 Q14416 1/20 0.34
DPP8 Q6V1X1 2/20 0.34
DPP9 Q86TI2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1007026 1.00 KDM4E (0.41) KDM4EL3MBTL1TSHRPOLBPKM
SCHEMBL1007025 1.00 KDM4E (0.41) KDM4EL3MBTL1TSHRPOLBPKM
SCHEMBL1008579 0.90 KDM4E (0.45) KDM4EL3MBTL1TSHRPOLBPKM
SCHEMBL6259122 0.90 KDM4E (0.45) KDM4EL3MBTL1TSHRPOLBPKM
SCHEMBL1008772 0.90 KDM4E (0.45) KDM4EL3MBTL1TSHRPOLBPKM
SCHEMBL1007513 0.84 L3MBTL1 (0.58) L3MBTL1POLBBCHEDPP4DPP7
SCHEMBL1007512 0.84 L3MBTL1 (0.58) L3MBTL1POLBBCHEDPP4DPP7
SCHEMBL1007934 0.84 L3MBTL1 (0.58) L3MBTL1POLBBCHEDPP4DPP7
SCHEMBL14292599 0.81 DPP4 (0.31) KDM4EBCHEDPP4MEN1KMT2A
SCHEMBL11920739 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105488-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2011-05-05 US claimed
EP-2268616-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN Chlorion Pharma, Inc. (CA) 2011-01-05 EP claimed
WO-2009114950-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN CHLORION PHARMA, INC. (CA) 2009-09-24 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105488-A1 SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN PAM, PNN, NOD1 KDM4E 1799/4885L3MBTL1 3671/4885TSHR 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.